Keywords: ribopharma, all, share, merger, alnylam, kulmbach, germany-headquartered

Ribopharma in all share merger with Alnylam

Article | 14 July 2003

Kulmbach, Germany-headquartered Ribopharma AG has merged with the USA's Alnylam Pharmaceuticals in a stock-for-stock deal that creates a leading biotechnology ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Alnylam Pharmaceuticals

Go to company listing

Related Drugs

Amino Acids

Injection

Physostigmine Salicylate

Go to drug listing